↓ Skip to main content

Autologous Mesenchymal Stem Cells for Treatment of Chronic Active Antibody-Mediated Kidney Graft Rejection: Report of the Phase I/II Clinical Trial Case Series

Overview of attention for article published in Transplant International, November 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (61st percentile)

Mentioned by

twitter
6 X users

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
14 Mendeley